Mizuho analyst John Roberts raised the firm’s price target on Chemours (CC) to $30 from $25 and keeps an Outperform rating on the shares.
Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CC:
- Chemours: Neutral Stance Maintained as Temporary HFC Tailwinds Offset Cautious Outlook; $18 Price Target Unchanged
- Chemours options imply 11.8% move in share price post-earnings
- Chemours Company (CC) Q1 Earnings Cheat Sheet
- Chemours Shareholders Approve 2026 Equity Incentive Plan
- Chemours price target raised to $30 from $27 at Truist
